Advanced Therapies of Movement Disorders

Fellowship Title:

Advanced Therapies of Movement Disorders

Division:

Neurology

Fellowship Type:

Clinical

Supervisor:

Dr. Alfonso Fasano

Duration:

1-2 Years (a 6-month rotation is also part of the 2-year clinical fellowship in Movement Disorders)

Application Open and Close Date:

Usually 2 years prior to start of fellowship

Anticipated Start Date(s):

July 1 (exceptions are possible)

Number of position(s) per year:

4 depending on funding

Description:

Specific targets are:

  • To know the scientific principles of deep brain stimulation (DBS), other experimental invasive neuromodulation techniques (e.g. spinal cord stimulation), MRI-guided focused ultrasound (MRgFUS), pump-based treatments (subcutaneous or intestinal) and shunt surgery
  • To know the pre-operative assessments (which tests should be done), including tap test for normal pressure hydrocephalus (NPH) and naso-jejunal test phase for intestinal levodopa-carbidopa gel infusion (LCIG)
  • To be able to personally perform CAPSIT and principal scales used in clinical scales, including principle of gait analysis
  • To know how to select the ideal neurosurgical procedure (DBS, MRgFUS, gamma-knife radiosurgery or radiofrequency lesioning)
  • To know the basic intra-operative neurophysiology and chronic brain recordings (e.g. local field potentials)
  • To assess the patient during awake surgery (DBS and MRgFUS)
  • To manage the immediate post-operative phase (medications, complications, botulinum toxin injection etc.)
  • To be able to program DBS for Vim, STN and GPi patients and manage the meds requirement
  • To be able to select and program children under consideration for DBS
  • To be able to program experimental devices, including adaptive DBS and novel targets
  • To be able to use neuroimaging-based and remote programming for DBS
  • To be able to program and manage shunt surgery for normal pressure hydrocephalus
  • To manage the principal complications or side effects after surgery or induced by the stimulation, drug infusion or CSF shunting
  • To manage the patients in long term follow-up, including telemedicine approaches

Contact Name:

Dr. Alfonso Fasano

Role:

Supervisor

E-mail:

alfonso.fasano@uhn.ca